OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
39
Results
Show all
Save search
Copy query
Show results for
Unknown
(39)
Publication Date
Release Date
2023
(8)
2024
(6)
2021
(6)
2025
(4)
2013
(3)
2020
(2)
2019
(2)
2018
(2)
2011
(2)
2022
(1)
2017
(1)
2016
(1)
2015
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
Role of Human N-Acetyltransferase 2 Genetic Polymorphism on Aromatic Amine Carcinogen-Induced DNA Damage and Mutagenicity in a Chinese Hamster Ovary Cell Mutation Assay.
Not available
S-EPMC7017392
|
biostudies-literature
Cite
Structure of Sodium Carboxymethyl Cellulose Aqueous Solutions: A SANS and Rheology Study.
Not available
S-EPMC4681322
|
biostudies-literature
Cite
Insecticide resistance compromises the control of Aedes aegypti in Bangladesh.
Not available
S-EPMC11694321
|
biostudies-literature
Cite
Examining relationships between perceptions and objective assessments of neighborhood environment and sedentary time: Data from the Washington, D.C. Cardiovascular Health and Needs Assessment.
Not available
S-EPMC5766749
|
biostudies-literature
Cite
Comparative analysis of 2-year outcomes in GRIT and TRUFFLE trials.
Not available
S-EPMC6973288
|
biostudies-literature
Cite
Differentiation of Prior SARS-CoV-2 Infection and Postacute Sequelae by Standard Clinical Laboratory Measurements in the RECOVER Cohort.
Not available
S-EPMC11408082
|
biostudies-literature
Cite
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial.
Not available
S-EPMC7615591
|
biostudies-literature
Cite
Frailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.
Not available
S-EPMC11390031
|
biostudies-literature
Cite
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial.
Not available
S-EPMC7618536
|
biostudies-literature
Cite
Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial.
Not available
S-EPMC12274867
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets